Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

The study in brief: Cancer research//Basic research//Peer review publication//Researcher-initiated study//Computer simulation//Animal study//In vitro/In vivo//In ...

Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours. Treatment for a ...

* New AI tool predicts both primary and hidden secondary drug targets across cancers * DeepTarget outperforms leading structural models in seven out of eight validation //tests * Offers a major boost ...

A formal FDA call for repurposing nominations prioritizes areas where unmet need is high and manufacturer incentives to pursue supplemental approvals are limited. Submissions may be grounded in ...